| API LIST奶茶原輔料的產品詳細信息 | |||||
No. | API Name主要藥用輔料稱謂 | CAS NO. | Indication應用癥 | Spec.的規格 | Stage環節 |
| 1 | Clindamycin Hydrochloride 硫酸克林霉素 | 21462-39-5 | Anti-infection 抗感梁 | FDA /CP/ CEP/USP | Commercial 企業化 |
| 2 | Clindamycin Phosphate | 24729-96-2 | Anti-infection 抗交叉感染 | FDA /CP/CEP/USP | Commercial 商業性化 |
| 3 | Amphotericin B (Oral & Injection) 倆性霉素 B（口服藥級&肌內注射級） | 1397-89-3 | Antifungal | CP/EP/USP | Commercial 商業運作化 |
| 4 | Clindamycin Palmitate Hydrochloride 硝酸克林霉素棕櫚酸酯 | 25507-04-4 | Anti-infection 抗婦科感染 | CP/EP/USP | Commercial 企業化 |
| 5 | Agomelatine 阿戈美拉汀 | 138112-76-2 | Anti-depression 抗焦慮癥 | INH 機構規格 | Commercial 服務業化 |
| 6 | Lactulose 乳蔗糖 | 4618-18-2 | Constipation 便秘現象 | INH 工廠標 | PV 校驗 |
| 7 | Vortioxetine Hydrobromide 氫溴酸沃替西汀 | 960203-27-4 | Anti-depression 制療輕度郁抑癥癥 | INH 廠家條件 | PV 校驗 |
| 8 | Netupitant 奈妥吡坦 | 290297-26-6 | Prevent Vomiting | INH 中小型企業標 | R&D 科研開發 |
| 9 | Fosnetupitant | 1703748-89-3 | Prevent Vomiting 放療嘔吐腹瀉 | INH 制造業企業標準 | R&D 新產品開發 |
| 10 | Anidulafungin | 166663-25-8 | Antifungal 抗白色念珠菌 | INH 的企業標準 | R&D 研發項目管理 |
| 11 | Caspofungin 卡泊芬凈 | 162808-62-0 | Antifungal 抗真菌感染 | INH 中小企業標淮 | R&D 新產品研發 |
| 12 | Carboprost Tromethamine | 58551-69-2 | 終止妊娠 | INH 工業企業原則 | R&D 研制 |
注：發明權期產品全部新產品開發便用Products under patent protection are for R&D only.
| Intermediate LIST其中體服務數據庫 | ||||
No. | Intermediate Name名稱 | CAS No. | Structure結構特征式 | Usage使用 |
| 1 | 7-Methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate 3,4-二氫-7-甲氧基-4-氧代喹唑啉-6-醇乙酸酯 | 179688-53-0 |  | Constructing core structure of EGFR inhibitors. EGFR克注射劑母核 |
| 2 | Methyl-d3-amine hydrochloride 氘代甲胺硝酸鹽 | 7436-22-8 |  | Deuterated building block. 氘代砌塊 |
| 3 | tert-Butyl (4R-cis)-6-Chloromethyl-2,2-dimethyl-1,3-dioxane-4-acetate 瑞舒伐他汀鈣D4之間體 | 154026-94-5 |  | Starting material of Rosuvastatin Calcium 瑞舒伐他汀多種維生素的啟始物料清單 |
| 4 | tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate 瑞舒伐他汀鈣D5之間體 | 154026-95-6 |  | |
| 5 | (R)-(+)-1-Boc-3-aminopyrrolidine (R)-(+)-1-Boc-3-氨基吡咯烷 | 147081-49-0 |  | Chiro building Block. For Ceftobiprole, Sunvozertinib, etc. 手性砌塊 |
| 6 | tert-butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate 4 - (6 -氨基吡啶- 3 -基)哌啶- 1 -甲酸叔丁酯 | 1198408-35-3 |  | Building Block. 提煉砌塊 |
| 7 | Vortioxetine 伏硫西汀 | 508233-74-7 |  | Intermediate of Vortioxetine 伏硫西汀中央體 |
| 8 | Vortioxetine Hydrochloric 伏硫西汀稀鹽酸鹽 | 960203-28-5 |  | |
| 9 | Di-tert-butyl Chloromethyl Phosphate | 229625-50-7 |  | Intermediate of Fosnetupitant 福奈妥匹坦中間的體 |
| 10 | N-tert-butyl-6-chloro-4-(o-tolyl)nicotinamide N-叔丁基-6-氯-4-鄰甲苯基煙酰胺 | 342417-04-3 |  | Intermediate of Netupitant and Fosnetupitant 奈妥匹坦中部體 |
| 11 | Methyl-[6-(4-methyl-piperazin-1-yl)-4-o-tolyl-pyridin-3-yl]-amine N-甲基-4-(2-甲基苯基)-6-(4-甲基-1-哌嗪基)-3-吡啶 胺 | 290297-25-5 |  | |
| 12 | (S)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionic acid (S)-2-三氟甲基-2-羥基丙酸 | 24435-45-8 |  | Building Block 生成砌塊 |
| 13 | (R)- 3,3,3-Trifluoro-2-hydroxy-2-methylpropionic acid (R)-2-三氟甲基-2-羥基丙酸 | 44864-47-3 |  | |
| 14 | (4-(2-(dimethylamino)ethoxy)phenyl)(4-hydroxyphenyl)methanone [4- [2-（二甲氨基氨基）乙氧基]苯基](4-羥苯基)甲酮 | 173163-13-8 |  | Building Block 聚合砌塊 |
| 15 | (S)-2-(diphenylmethyl)pyrrolidine (2S)-2-(二苯基甲基)吡咯烷 | 119237-64-8 |  | Chiral catalyst 手性促使劑 |
| 16 | (R)-2-(diphenylmethyl)pyrrolidine (2R)-2-(二苯基甲基)吡咯烷 | 22348-31-8 |  | |
注：著作權期成品只供科研用Products under patent protection are for R&D only.
Cosmetic & Health Product Efficacious Ingredients美妝和保健理療品效果成份 | |||||
| No. | Name商品名稱 | CAS No. | Efficacy自我調節癥 | Spec. 規格尺寸 | Stage階段性 |
| 1 | Ectoin 依克多因 | 96702-03-3 | Hydrate and Encase moisture | INH 工廠標 | Commercial商業服務化 |
| 2 | NRH 還原成型煙酰胺核糖 | 19132-12-8 | Anti-aging | INH 制造業企業標 | R&D 研發項目管理 |
| 3 | N-Acetyl-L-Carnosine N-乙酰基肌肽 | 56353-15-2/56353-23-0 | Anti-Oxidant and Anti-Glycation | INH 中小型企業標準規定 | R&D 技術創新 |
注：專利技術期新產品僅限研發管理用到Products under patent protection are for R&D only.
